Mulvihill, Erin E <br/><br/>
Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance.  [electronic resource] 

 -  Diabetes  Oct 2009 
 - 2198-210 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1939-327X 
<br/><br/><label>Standard No.: </label>10.2337/db09-0634  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alanine Transaminase--blood<br/>Animals<br/>Anti-Ulcer Agents--pharmacology<br/>Apolipoproteins B--biosynthesis<br/>Aspartate Aminotransferases--blood<br/>Blood Glucose--metabolism<br/>Body Weight<br/>DNA, Mitochondrial--genetics<br/>Dietary Fats--pharmacology<br/>Dyslipidemias--prevention & control<br/>Energy Intake<br/>Estrogen Antagonists--pharmacology<br/>Flavanones--pharmacology<br/>Glucose Tolerance Test<br/>Insulin--blood<br/>Insulin Resistance--physiology<br/>Lipoproteins, VLDL--metabolism<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Receptors, LDL--deficiency<br/>Triglycerides--metabolism